InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Paul B Manning, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 4 companies. The public record shows 25 open-market SEC Form 4 transactions: 22 purchases worth $75.1M and 3 sales worth $16.8M, reported from Jul 27, 21 to Feb 23, 26. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 26 | CADLCandel Therapeutics, Inc. | BUY | 550.5K | $5.45 | $3.0M |
| Nov 25, 25 | VRCAVerrica Pharmaceuticals Inc. | BUY | 2.75M | $4.24 | $11.7M |
| Sep 2, 25 | LQDALiquidia Corp | SELL | 254.0K | $29.14 | $7.3M |
| Aug 29, 25 | LQDALiquidia Corp | SELL | 188.2K | $27.62 | $5.2M |
| Aug 28, 25 | LQDALiquidia Corp | SELL | 154.3K | $27.94 | $4.3M |
| May 30, 25 | TSHATaysha Gene Therapies, Inc. | BUY | 750.0K | $2.75 | $2.1M |
| Dec 16, 24 | CADLCandel Therapeutics, Inc. | BUY | 750.0K | $6.00 | $4.5M |
| Nov 22, 24 | VRCAVerrica Pharmaceuticals Inc. | BUY | 18.43M | - | $0 |
| Sep 12, 24 | LQDALiquidia Corp | BUY | 337.1K | $8.90 | $3.0M |
| Jun 27, 24 | TSHATaysha Gene Therapies, Inc. | BUY | 1.33M | $2.25 | $3.0M |
| Dec 14, 23 | LQDALiquidia Corp | BUY | 279.3K | $7.16 | $2.0M |
| Nov 17, 23 | TSHATaysha Gene Therapies, Inc. | BUY | 100.0K | $1.63 | $163K |
| Aug 16, 23 | TSHATaysha Gene Therapies, Inc. | BUY | 16.47M | $0.90 | $14.8M |
| Jul 24, 23 | VRCAVerrica Pharmaceuticals Inc. | BUY | 200.0K | $5.02 | $1.0M |
| Oct 31, 22 | TSHATaysha Gene Therapies, Inc. | BUY | 1.50M | $2.00 | $3.0M |
| Jul 5, 22 | VRCAVerrica Pharmaceuticals Inc. | BUY | 4.76M | $2.10 | $10.0M |
| Apr 18, 22 | LQDALiquidia Corp | BUY | 392.2K | $5.10 | $2.0M |
| Feb 3, 22 | TSHATaysha Gene Therapies, Inc. | BUY | 50.0K | $7.84 | $392K |
| Feb 2, 22 | TSHATaysha Gene Therapies, Inc. | BUY | 58.0K | $7.77 | $451K |
| Dec 3, 21 | VRCAVerrica Pharmaceuticals Inc. | BUY | 20.0K | $9.22 | $184K |
| Dec 2, 21 | VRCAVerrica Pharmaceuticals Inc. | BUY | 30.0K | $9.45 | $284K |
| Nov 24, 21 | TSHATaysha Gene Therapies, Inc. | BUY | 2.2K | $13.19 | $29K |
| Nov 23, 21 | TSHATaysha Gene Therapies, Inc. | BUY | 20.0K | $12.54 | $251K |
| Jul 29, 21 | CADLCandel Therapeutics, Inc. | BUY | 1.63M | $8.00 | $13.0M |
| Jul 27, 21 | CADLCandel Therapeutics, Inc. | BUY | 36.0K | $7.36 | $265K |